Home > Insider Trading > Filing (0001225208-14-003800)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
912513	Cytec Industries Inc	CYT	Miscellaneous Chemical Products (2890)	223268660

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1309051	D Shane Fleming	Five Garret Mountain Plaza Woodland Park NJ 07424	Chairman,President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-07	15,000	$47.59	32,272	No	4	M	Direct
Common Stock	Acquisiton	2014-02-07	9,966	$0.00	42,238	No	4	M	Direct
Common Stock	Disposition	2014-02-07	9,966	$90.24	32,272	No	4	S	Direct
Common Stock	Disposition	2014-02-07	15,000	$89.73	17,272	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option Right to buy	Disposition	2014-02-07	15,000	$0.00	15,000	$47.59
Common Stock	Stock Appreciation Right	Disposition	2014-02-07	22,000	$90.48	22,000	$49.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2006-01-19	2015-01-18	No	4	M	Direct
0	2007-02-08	2016-02-07	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	25,217	Indirect	Savings Plan
Common Stock	24,524	Indirect	Supplemental Savings Plan

Footnotes

Pursuant to the exercise of stock settled appreciation rights, Mr. Fleming received 9,966 shares without payment of any consideration.
The sales price ranged from $90.00 to $90.59 with a weighted average of $90.2352. The undersigned reporting person hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The sales price ranged from $89.31 to $90.545 with a weighted average of $89.7304. The undersigned reporting person hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Excludes shares held in Employees' Savings Plan or Supplemental Plan which are eligible for deferred reporting on Form 5, as per note to instruction 4(a)(i).